Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up

(2012) Angel Vila-Corcoles et al.   BMC PUBLIC HEALTH

Combat Pneumococcal Infections: Adhesins as Candidates for Protein- Based Vaccine Development

(2012) Gustavo Gamez et al.   CURRENT DRUG TARGETS

Vaccines of the future

(2011) G.J.V. Nossal   VACCINE

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke

(2010) Angel Vila-Corcoles et al.   BMC PUBLIC HEALTH

Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly

(2010) A. Dominguez et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Is the pneumococcal polysaccharide vaccine effective in preventing pneumonia?

(2008) Angel Vila-Corcoles   LANCET INFECTIOUS DISEASES